Skip to main content

International Journal of Clinical Oncology

Ausgabe 5/2014

Inhalt (26 Artikel)

Original Article

Questionnaire survey for the development and publication of cancer clinical practice guidelines in Japan

Tomohisa Furuhata, Koichi Hirata, Fumihiko Wakao, Kenji Okita, Masafumi Imamura, Yoshihiko Maehara, Masahiko Nishiyama

Publisher's Erratum

Erratum to: Questionnaire survey for the development and publication of cancer clinical practice guidelines in Japan

Tomohisa Furuhata, Koichi Hirata, Fumihiko Wakao, Kenji Okita, Masafumi Imamura, Yoshihiko Maehara, Masahiko Nishiyama

Introduction to Review Articles

Controversies in managing localized prostate cancer: introduction

Yoichi Arai

Review Article

Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen

Kazuto Ito, Yuji Fujizuka, Kiyohide Ishikura, Bernard Cook

Original Article

Low expression of sodium iodide symporter expression in aggressive variants of papillary thyroid carcinoma

Songfeng Wei, Ming Gao, Cui Zhao, Yi Pan, Haixin Li, Jian Li, Xiaolong Li

Original Article

Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation

Katsuyuki Sakanaka, Yukinori Matsuo, Yasushi Nagata, Sayo Maki, Keiko Shibuya, Yoshiki Norihisa, Masaru Narabayashi, Nami Ueki, Takashi Mizowaki, Masahiro Hiraoka

Original Article

Retrospective review of extra-pulmonary small cell carcinoma and prognostic factors

Jonathan Edward Brammer, Premal Lulla, Garrett Rushing Lynch

Original Article

Massage interventions and treatment-related side effects of breast cancer: a systematic review and meta-analysis

Yuan Q. Pan, Ke H. Yang, Yu L. Wang, Lai P. Zhang, Hai Q. Liang

Original Article

Subcellular localization of Mdm2 expression and prognosis of breast cancer

Hyung Seok Park, Ji Min Park, Seho Park, Junghoon Cho, Seung Il Kim, Byeong-Woo Park

Original Article

Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan

Hiroyasu Yamashiro, Masahiro Takada, Eiji Nakatani, Shiro Imai, Akira Yamauchi, Shigeru Tsuyuki, Yasuo Matsutani, Shingo Sakata, Yasuo Wada, Ryuji Okamura, Tomika Harada, Fumie Tanaka, Yoshio Moriguchi, Hironori Kato, Shunichi Higashide, Norimichi Kan, Hiroshi Yoshibayashi, Hirofumi Suwa, Takashi Okino, Ichiro Nakayama, You Ichinose, Kazuhiko Yamagami, Takashi Hashimoto, Takashi Inamoto, Masakazu Toi

Original Article

Efficacy of S-1 plus cisplatin combination chemotherapy in patients with HER2-positive advanced gastric cancer

Yoshitaka Honma, Yasuhiro Shimada, Atsuo Takashima, Satoru Iwasa, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Hirokazu Taniguchi, Shigeki Sekine, Ryoji Kushima

Original Article

Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization

Takuma Arai, Akira Kobayashi, Ayumi Ohya, Masaaki Takahashi, Takahide Yokoyama, Akira Shimizu, Hiroaki Motoyama, Norihiko Furusawa, Tsuyoshi Notake, Noriyuki Kitagawa, Hiroshi Sakai, Hiroshi Imamura, Masumi Kadoya, Shin-ichi Miyagawa

Original Article

Expression and prognostic value of Ars2 in hepatocellular carcinoma

Qian He, Yongde Huang, Lei Cai, Shaobo Zhang, Chenghua Zhang

Original Article

Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer

Deniz Tural, Fatih Selcukbiricik, Özcan Yıldız, Olgun Elcin, Sibel Erdamar, Sabri Güney, Fuat Demireli, Evin Büyükünal, Süheyla Serdengeçti

Original Article

Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan

Tadao Takano, Hitoshi Niikura, Kiyoshi Ito, Satoru Nagase, Hiroki Utsunomiya, Takeo Otsuki, Masafumi Toyoshima, Hideki Tokunaga, Michiko Kaiho-Sakuma, Naomi Shiga, Tomoyuki Nagai, Sota Tanaka, Ai Otsuki, Hiroki Kurosawa, Shogo Shigeta, Keita Tsuji, Takuhiro Yamaguchi, Nobuo Yaegashi

Original Article

Importance of uterine cervical cerclage to maintain a successful pregnancy for patients who undergo vaginal radical trachelectomy

Miseon Kim, Shin-ichi Ishioka, Toshiaki Endo, Tsuyoshi Baba, Yushi Akashi, Miyuki Morishita, Hidefumi Adachi, Tsuyoshi Saito

Original Article

Prognostic predictors and spread patterns in adult ovarian granulosa cell tumors: a multicenter long-term follow-up study of 108 patients

Ibrahim Egemen Ertas, Kemal Gungorduk, Salih Taskin, Levent Akman, Aykut Ozdemir, Rifat Goklu, Mustafa Cosan Terek, Aydin Ozsaran, Yilmaz Dikmen, Yusuf Yildirim, Firat Ortac

Original Article

A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age

Hiroaki Kajiyama, Mika Mizuno, Kiyosumi Shibata, Tomokazu Umezu, Shiro Suzuki, Eiko Yamamoto, Hiroko Mitsui, Ryuichiro Sekiya, Kaoru Niimi, Michiyasu Kawai, Tetsuro Nagasaka, Fumitaka Kikkawa

Original Article

Isomorphic red blood cells using automated urine flow cytometry is a reliable method in diagnosis of bladder cancer

Satoru Muto, Syo-ichiro Sugiura, Akiko Nakajima, Akira Horiuchi, Masahiro Inoue, Keisuke Saito, Shuji Isotani, Raizo Yamaguchi, Hisamitsu Ide, Shigeo Horie

Original Article

Factors predicting incisional surgical site infection in patients undergoing open radical cystectomy for bladder cancer

Tatsuo Gondo, Yoshio Ohno, Jun Nakashima, Takeshi Hashimoto, Issei Takizawa, Ayako Tanaka, Kenji Shimodaira, Naoya Satake, Hisashi Takeuchi, Yoshihiro Nakagami, Makoto Ohori, Masaaki Tachibana

Original Article

Five-year potency preservation after iodine-125 prostate brachytherapy

Shuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, Masanori Sakayori, Yasuto Yagi, Toru Nishiyama, Shiro Saito, Yutaka Shiraishi, Kayo Yoshida, Kazuhito Toya, Naoyuki Shigematsu

Original Article

Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer

Hideyasu Matsuyama, Tomoyuki Shimabukuro, Isao Hara, Yasuo Kohjimoto, Kazuhiro Suzuki, Hidekazu Koike, Hirotsugu Uemura, Taiji Hayashi, Munehisa Ueno, Kiichiro Kodaira, Yoshihiko Tomita, Toshihiko Sakurai, Nobuaki Shimizu

Original Article

Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates

Koichiro Yamakado, Akihiko Matsumine, Tomoki Nakamura, Atsuhiro Nakatsuka, Haruyuki Takaki, Takao Matsubara, Kunihiro Asanuma, Akihiro Sudo, Yoshiki Sugimura, Hajime Sakuma

Original Article

Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005–2009 and a comparison with those treated in 1985–2004

Yuta Shibamoto, Minako Sumi, Shunsuke Onodera, Haruo Matsushita, Chikao Sugie, Yukihisa Tamaki, Hiroshi Onishi, Eisuke Abe, Masahiko Koizumi, Daisuke Miyawaki, Seiji Kubota, Etsuyo Ogo, Takuma Nomiya, Mitsuhiro Takemoto, Hideyuki Harada, Ippei Takahashi, Yoshio Ohmori, Naoya Ishibashi, Sunao Tokumaru, Kazunori Suzuki

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.